Sampling variablity of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens

World Journal of Gastroenterology

Volumn 12, Issue 47, 2006, Pages 7660-7665

  Grizzi, Fabio ^a   Russo, Carlo ^a   Franceschini, Barbara ^a   Di Rocco, Mariagrazia ^a   Torri, Valter ^b   Morenghi, Emanuela ^a   Fassati, Luigi Rainero ^c   Dioguardi, Nicola ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cirrhosis; Extra cellular matrix; Hepatitis C virus; Image analysis; Inter sample variability

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; NEEDLE BIOPSY; QUALITATIVE DIAGNOSIS; SAMPLING; TISSUE CHARACTERIZATION; TISSUE SECTION; TISSUE STRUCTURE; BIOLOGICAL MODEL; FRACTAL ANALYSIS; LIVER; METHODOLOGY; PATHOLOGY;

BIOPSY, NEEDLE; DIAGNOSIS, COMPUTER-ASSISTED; FRACTALS; HUMANS; LIVER; LIVER CIRRHOSIS; MODELS, BIOLOGICAL;

EID: 33845979826     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i47.7660     Document Type: Article

References (58)

1. Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med 2001; 344: 452-454
2. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40: 860-867
3. Fallowfield JA, Iredale JP. Reversal of liver fibrosis and cirrhosis - an emerging reality. Scott Med 12004, 49: 3-6
4. Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, Bedossa P, Brechot C. Reversibility of hepatitis C virus-related cirrhosis. Hum Pathol 2004; 35: 107-112
5. Desmet VJ. Comments on cirrhosis reversal. Dig Liver Dis 2005; 37: 909-916
6. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004; 3: 8
7. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004; 10: 429-434
8. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54
9. Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, Lin R, Samarasinghe D, Liddle C, McCaughan GW, George J. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004, 39: 1239-1247
10. Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-1713
11. Patel Y, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004; 41: 935-42
12. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75
13. Yamada H, Ebara M, Yamaguchi T, Okabe S, Fukuda H, Yoshikawa M, Kishimoto T, Matsubara. H, Hachiya H, Ishikura H, Saisho H. A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. J Hepatol 2006; 44: 68-75
14. Desmet VJ. Liver tissue examination. J Hepatol 2003; 39 Suppl 1: S43-S49
15. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500
16. Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005; 25: 52-64
17. Desmet V, Fevery J. Liver biopsy. Baillieres Clin Gastroenterol 1995; 9: 811-828
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
19. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374
20. Ishak Y, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
21. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293
22. Hubscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998; 29: 1015-1022
23. Scheuer PJ. Assessment of liver biopsies in chronic hepatitis: how is it best done? J Hepatol 2003; 30: 240-242
24. Rosenberg WM. Rating fibrosis progression in chronic liver diseases. J Hepatol 2003; 38: 357-360
25. Lagging LM, Westin J, Svensson E, Aires N, Dhillon AP, Lindh M, Wejstal R, Norkrans G. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002; 22: 136-144
26. Svensson E. Ordinal invariant measures for individual and group changes in ordered categorical data. Stat Med 1998; 17: 2923-2936
27. Masseroli M, Caballero T, O'Valle F, Del Moral RM, Perez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000; 32: 453-464
28. Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga. MY, Gallois Y, Cales P. Histopathological evaluation of liver fibrosis: quantitative image analysis vs seirti-quantitative scores. Comparison with serum markers. J Hepatol 1998; 28: 439-446
29. Wright M, Thursz M, Pullen R, Thomas H, Goldin R. Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimation. Liver Int 2003; 23: 28-34
30. Dioguardi N, Grizzi F, Bossi P, Roncalli M. Fractal and spectral dimension analysis of liver fibrosis in needle biopsy specimens. Anal Quant Cytol Histol 1999; 21: 262-266
31. Grizzi F, Dioguardi N. A fractal scoring system for quantifying active collagen synthesis during chronic liver disease. Int J Chaos Theor Appl 1999; 4: 39-44
32. Dioguardi N, Franceschini B, Aletti G, Russo C, Grizzi F. Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol 2003; 25: 312-320
33. Dioguardi N, Grizzi F, Franceschini B, Bossi P, Russo C. Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst's exponent. World J Gastroenterol 2006; 12: 2187-2194
34. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
35. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003; 38: 427-432
36. Olsson R, Hagerstrand I, Broome U, Danielsson A, Jarnerot G, Loof L, Prytz H, Ryden BO, Wallerstedt S Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995; 48: 933-935
37. Imamura H, Kawasaki S, Bandai Y, Sanjo K, Idezuki Y. Comparison between wedge and needle biopsies for evaluating the degree of cirrhosis. J Hepatol 1993; 17: 215-219
38. Gluud C. Sampling variability in percutaneous liver biopsy. Lancet 1986; 1: 975
39. Maharaj B, Maharaj RJ, Leary WP, Cooppan RK, Naran AD, Pirie D, Pudifin DJ. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525
40. Layden TJ. Percutaneous needle biopsy specimens. Sampling variability in patients with chronic hepatitis and cirrhosis. Arch Intern Med 1979; 139: 856
41. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-669
42. Dioguardi N, Franceschini B, Russo C, Grizzi F. Computer-aided morphometry of liver inflammation in needle biopsies. World J Gastroenterol 2005; 11: 6995-7000
43. Junqueira LC, Bignolas G, Brentard RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-455
44. Bassingthwaighte JB, Liebovitch LS, West BJ. Fractal Physiology. New York: Oxford University Press, 1994
45. Hastings HM, Sugihara G. Fractals. A User's Guide for the Natural Sciences. Oxford Science Publications: Oxford, 1993
46. Dioguardi N, Grizzi F. Fractal dimension exponent for quantitative evaluation of liver collagen in bioptic specimens. In "Mathematics and biosciences in interaction", Basel, Boston, Berlin: Birkhauser Press, 2001: 113-120
47. Hurst HE. Long-term storage capacity of reservoirs. Trans Am Soc Civ Eng 1951; 116: 770-808
48. Hurst HE, Black RP, Simaiki YM. Long-term storage: an experimental study. London: Constable, 1965
49. Bassingthwaighte JB, Raymond GM. Evaluation of the dispersional analysis method for fractal time series. Ann Biomed Eng 1995; 23: 491-505
50. Herrine SK Friedman LS. Divining the role of liver biopsy in hepatitis C. J Hepatol 2005; 43: 374-376
51. Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem 2004; 50: 1299-1300
52. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003; 37: 972-974
53. Tao J, Peng HQ, Cai WM, Dong FQ, Weng HL, Liu RH. Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 2003; 9: 2497-2500
54. Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol 2002; 8: 1073-1076
55. Rosenthal-Allieri MA, Peritore ML, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins. Clin Biochem 2005; 38: 473-478
56. Ghany MG, Doo E. Assessment of liver fibrosis: palpate, poke or pulse? Hepatology 2005; 42: 759-761
57. Dufour DR. Assessment of liver fibrosis: Can serum become the sample of choice? Clin Chem 2005; 51: 1763-1764
58. Wanless IR. Liver biopsy in the diagnosis of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 281-5, vii